Clinical trial
Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney…
NCT00228436 · Affymax, Industry · Completed
Key facts
| NCT number | NCT00228436 |
|---|---|
| Title | Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients |
| Official title | A Phase 2, Open-label, Multi-center, Sequential Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Multiple Doses of Subcutaneously Administered Peginesatide in Chronic Kidney Disease Patients Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment |
| Lead sponsor | Affymax, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | peginesatide |
| Enrollment | 139 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Dec 21, 2012 |
| Countries | Poland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: